The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cabazitaxel Market Research Report 2024
Synopsis
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
The global Cabazitaxel market was valued at US$ 203.5 million in 2023 and is anticipated to reach US$ 293.4 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
USA is the largest Cabazitaxel market with about 95% market share. Europe is follower, accounting for about 3% market share.The key manufacturers are Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological etc. Top 3 companies occupied about 99% market share.
This report aims to provide a comprehensive presentation of the global market for Cabazitaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cabazitaxel.
Report Scope
The Cabazitaxel market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cabazitaxel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cabazitaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
Segment by Type
Purity above 99%
Other Purity
Segment by Application
Age Below 65
Age Above 65
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cabazitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cabazitaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
The global Cabazitaxel market was valued at US$ 203.5 million in 2023 and is anticipated to reach US$ 293.4 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
USA is the largest Cabazitaxel market with about 95% market share. Europe is follower, accounting for about 3% market share.The key manufacturers are Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological etc. Top 3 companies occupied about 99% market share.
This report aims to provide a comprehensive presentation of the global market for Cabazitaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cabazitaxel.
Report Scope
The Cabazitaxel market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cabazitaxel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cabazitaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
Segment by Type
Purity above 99%
Other Purity
Segment by Application
Age Below 65
Age Above 65
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cabazitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cabazitaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cabazitaxel Market Overview
1.1 Product Overview and Scope of Cabazitaxel
1.2 Cabazitaxel Segment by Type
1.2.1 Global Cabazitaxel Market Value Comparison by Type (2024-2030)
1.2.2 Purity above 99%
1.2.3 Other Purity
1.3 Cabazitaxel Segment by Application
1.3.1 Global Cabazitaxel Market Value by Application: (2024-2030)
1.3.2 Age Below 65
1.3.3 Age Above 65
1.4 Global Cabazitaxel Market Size Estimates and Forecasts
1.4.1 Global Cabazitaxel Revenue 2019-2030
1.4.2 Global Cabazitaxel Sales 2019-2030
1.4.3 Global Cabazitaxel Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cabazitaxel Market Competition by Manufacturers
2.1 Global Cabazitaxel Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cabazitaxel Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cabazitaxel Average Price by Manufacturers (2019-2024)
2.4 Global Cabazitaxel Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cabazitaxel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cabazitaxel, Product Type & Application
2.7 Cabazitaxel Market Competitive Situation and Trends
2.7.1 Cabazitaxel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cabazitaxel Players Market Share by Revenue
2.7.3 Global Cabazitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cabazitaxel Retrospective Market Scenario by Region
3.1 Global Cabazitaxel Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cabazitaxel Global Cabazitaxel Sales by Region: 2019-2030
3.2.1 Global Cabazitaxel Sales by Region: 2019-2024
3.2.2 Global Cabazitaxel Sales by Region: 2025-2030
3.3 Global Cabazitaxel Global Cabazitaxel Revenue by Region: 2019-2030
3.3.1 Global Cabazitaxel Revenue by Region: 2019-2024
3.3.2 Global Cabazitaxel Revenue by Region: 2025-2030
3.4 North America Cabazitaxel Market Facts & Figures by Country
3.4.1 North America Cabazitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cabazitaxel Sales by Country (2019-2030)
3.4.3 North America Cabazitaxel Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cabazitaxel Market Facts & Figures by Country
3.5.1 Europe Cabazitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cabazitaxel Sales by Country (2019-2030)
3.5.3 Europe Cabazitaxel Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cabazitaxel Market Facts & Figures by Country
3.6.1 Asia Pacific Cabazitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cabazitaxel Sales by Country (2019-2030)
3.6.3 Asia Pacific Cabazitaxel Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cabazitaxel Market Facts & Figures by Country
3.7.1 Latin America Cabazitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cabazitaxel Sales by Country (2019-2030)
3.7.3 Latin America Cabazitaxel Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cabazitaxel Market Facts & Figures by Country
3.8.1 Middle East and Africa Cabazitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cabazitaxel Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cabazitaxel Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cabazitaxel Sales by Type (2019-2030)
4.1.1 Global Cabazitaxel Sales by Type (2019-2024)
4.1.2 Global Cabazitaxel Sales by Type (2025-2030)
4.1.3 Global Cabazitaxel Sales Market Share by Type (2019-2030)
4.2 Global Cabazitaxel Revenue by Type (2019-2030)
4.2.1 Global Cabazitaxel Revenue by Type (2019-2024)
4.2.2 Global Cabazitaxel Revenue by Type (2025-2030)
4.2.3 Global Cabazitaxel Revenue Market Share by Type (2019-2030)
4.3 Global Cabazitaxel Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cabazitaxel Sales by Application (2019-2030)
5.1.1 Global Cabazitaxel Sales by Application (2019-2024)
5.1.2 Global Cabazitaxel Sales by Application (2025-2030)
5.1.3 Global Cabazitaxel Sales Market Share by Application (2019-2030)
5.2 Global Cabazitaxel Revenue by Application (2019-2030)
5.2.1 Global Cabazitaxel Revenue by Application (2019-2024)
5.2.2 Global Cabazitaxel Revenue by Application (2025-2030)
5.2.3 Global Cabazitaxel Revenue Market Share by Application (2019-2030)
5.3 Global Cabazitaxel Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Cabazitaxel Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Cabazitaxel Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Tapi Teva
6.2.1 Tapi Teva Corporation Information
6.2.2 Tapi Teva Description and Business Overview
6.2.3 Tapi Teva Cabazitaxel Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Tapi Teva Cabazitaxel Product Portfolio
6.2.5 Tapi Teva Recent Developments/Updates
6.3 Fuan Pharmaceutical Group
6.3.1 Fuan Pharmaceutical Group Corporation Information
6.3.2 Fuan Pharmaceutical Group Description and Business Overview
6.3.3 Fuan Pharmaceutical Group Cabazitaxel Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fuan Pharmaceutical Group Cabazitaxel Product Portfolio
6.3.5 Fuan Pharmaceutical Group Recent Developments/Updates
6.4 Fujian Yewpark Biological
6.4.1 Fujian Yewpark Biological Corporation Information
6.4.2 Fujian Yewpark Biological Description and Business Overview
6.4.3 Fujian Yewpark Biological Cabazitaxel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fujian Yewpark Biological Cabazitaxel Product Portfolio
6.4.5 Fujian Yewpark Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cabazitaxel Industry Chain Analysis
7.2 Cabazitaxel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cabazitaxel Production Mode & Process
7.4 Cabazitaxel Sales and Marketing
7.4.1 Cabazitaxel Sales Channels
7.4.2 Cabazitaxel Distributors
7.5 Cabazitaxel Customers
8 Cabazitaxel Market Dynamics
8.1 Cabazitaxel Industry Trends
8.2 Cabazitaxel Market Drivers
8.3 Cabazitaxel Market Challenges
8.4 Cabazitaxel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
